Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background

Sakthivel Sadayappan1, James Gulick, Raisa Klevitsky

  • 1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Ohio, USA.

Circulation
|February 25, 2009
PubMed
Abstract

Insights

Cardiac myosin binding protein-C (cMyBP-C) phosphorylation is essential for normal heart function in a beta-myosin heavy chain (beta-MyHC) environment. This phosphorylation also protects the heart from ischemia/reperfusion injury, suggesting therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cardiac Muscle Physiology

Background:

  • Cardiac myosin binding protein-C (cMyBP-C) phosphorylation is a key regulator of cardiac contractility.
  • Previous studies in alpha-myosin heavy chain (alpha-MyHC) hearts showed cMyBP-C phosphomimetics rescued cardiac dysfunction.
  • The relevance to human hearts, which predominantly express beta-myosin heavy chain (beta-MyHC), remained unclear.

Purpose of the Study:

  • To investigate the role of cMyBP-C phosphorylation in a beta-MyHC background.
  • To determine if cMyBP-C phosphorylation is essential for cardiac function in beta-MyHC hearts.
  • To assess the cardioprotective effects of cMyBP-C phosphorylation against ischemia/reperfusion injury in a beta-MyHC context.

Main Methods:

  • Generated transgenic mice expressing different forms of cMyBP-C (WT, nonphosphorylatable, phosphomimetic) in a beta-MyHC background.
  • Crossed these mice into a cMyBP-C-null background to eliminate endogenous cMyBP-C.
  • Assessed cardiac function, survival, and response to ischemia/reperfusion injury.

Main Results:

  • Mice lacking functional cMyBP-C phosphorylation in the beta-MyHC background (cMyBP-C(AllP)(-):(t/t)/beta) exhibited premature death due to heart failure.
  • Hearts expressing phosphomimetic or wild-type cMyBP-C in the beta-MyHC background showed no significant morbidity or mortality.
  • Phosphomimetic cMyBP-C significantly protected these hearts from ischemia/reperfusion injury.

Conclusions:

  • cMyBP-C phosphorylation is critical for maintaining basal myocardial function in the beta-MyHC environment.
  • cMyBP-C phosphorylation confers significant protection against ischemia/reperfusion injury in the human-relevant beta-MyHC background.
  • Targeting cMyBP-C phosphorylation represents a promising therapeutic strategy for human heart conditions.

Related Concept Videos

Overview of Myosin Structure and Function01:15

Overview of Myosin Structure and Function

Myosins are a family of molecular motor proteins, first identified in the skeletal muscles, where they are responsible for muscle contraction. Along with their role in muscle contraction, these proteins also play a role in the intracellular transport of molecules and vesicles. There are twenty-four classes of myosins based on their domain sequence and organization. Of the twenty-four, six classes (Myosin I, Myosin II, Myosin V, Myosin VI, Myosin VII, and Myosin X)  have been well characterized.
Actin and Myosin in Muscle Contraction01:16

Actin and Myosin in Muscle Contraction

Actin and myosin are contractile proteins that form the sarcomere found in skeletal muscle tissues for regulating muscle contraction. Actin, a globular contractile protein, interacts with myosin for muscle contraction. The skeletal tissue appears striped or striated under a microscope due to the repeated arrangement of contractile proteins actin and myosin along the length of myofibrils. Dark A bands and light I bands repeat along myofibrils, and the alignment of myofibrils in the cell causes...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...